Search research articles
Contact Us
Filters
Showing results (181-190 of 224) with videos related to
Page
of 23
Sort By:
Frontiers in Oncology
|
August 5, 2022
A Phase II Study Evaluating the Interest to Combine UCPVax, a Telomerase CD4 T<sub>H</sub>1-Inducer Cancer Vaccine, and Atezolizumab for the Treatment of HPV Positive Cancers: VolATIL Study
Magali Rebucci-Peixoto, Angélique Vienot, Olivier Adotevi, et al.
BMJ Oncology
|
January 31, 2025
Predictive biomarkers and specific immune responses of COVID-19 mRNA vaccine in patients with cancer: prospective results from the CACOV-VAC trial
Laurie Spehner, Emeline Orillard, Antoine Falcoz, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)
|
December 13, 2017
Value of Contrast-Enhanced Ultrasound Quantification Criteria for Identifying Patients not Responding to Bevacizumab-Based Therapy for Colorectal Liver Metastases
François Tranquart, Paul-Armand Dujardin, Olivier Bouché, et al.
Bulletin Du Cancer
|
February 15, 2020
[Localized MSI/dMMR gastric cancer patients, perioperative immunotherapy instead of chemotherapy: The GERCOR NEONIPIGA phase II study is opened to recruitment]
Romain Cohen, Thomas Pudlarz, Marie-Line Garcia-Larnicol, et al.
Seminars in Oncology
|
April 12, 2017
Prevention of 5-fluorouracil-induced early severe toxicity by pre-therapeutic dihydropyrimidine dehydrogenase deficiency screening: Assessment of a multiparametric approach
Michele Boisdron-Celle, Olivier Capitain, Roger Faroux, et al.
Clinical Colorectal Cancer
|
July 18, 2019
Efficacy and Safety of Two Neoadjuvant Strategies With Bevacizumab in MRI-Defined Locally Advanced T3 Resectable Rectal Cancer: Final Results of a Randomized, Noncomparative Phase 2 INOVA Study
Christophe Borg, Georges Mantion, Frank Boudghène, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
July 4, 2019
Infiltrating and peripheral immune cell analysis in advanced gastric cancer according to the Lauren classification and its prognostic significance
Simon Pernot, Magali Terme, Nina Radosevic-Robin, et al.
The Journal of Clinical Investigation
|
January 23, 2010
Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells
Fanny Chalmin, Sylvain Ladoire, Grégoire Mignot, et al.
Gastroenterology
|
November 29, 2024
ERBB2 Comprehensive Profiling and Prognostication in Stage III Colon Cancer: Findings From PETACC8 and IDEA-France Cohorts
Camilla Pilati, Audrey Soulabaille, Claire Gallois, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 9, 2008
EPIC: phase III trial of cetuximab plus irinotecan after fluoropyrimidine and oxaliplatin failure in patients with metastatic colorectal cancer
Alberto F Sobrero, Joan Maurel, Louis Fehrenbacher, et al.
Page
of 23
Search research articles
Search
Showing results (181-190 of 224) with videos related to
Sort By:
Page
of 23
Frontiers in Oncology
|
August 5, 2022
A Phase II Study Evaluating the Interest to Combine UCPVax, a Telomerase CD4 T<sub>H</sub>1-Inducer Cancer Vaccine, and Atezolizumab for the Treatment of HPV Positive Cancers: VolATIL Study
Magali Rebucci-Peixoto, Angélique Vienot, Olivier Adotevi, et al.
BMJ Oncology
|
January 31, 2025
Predictive biomarkers and specific immune responses of COVID-19 mRNA vaccine in patients with cancer: prospective results from the CACOV-VAC trial
Laurie Spehner, Emeline Orillard, Antoine Falcoz, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)
|
December 13, 2017
Value of Contrast-Enhanced Ultrasound Quantification Criteria for Identifying Patients not Responding to Bevacizumab-Based Therapy for Colorectal Liver Metastases
François Tranquart, Paul-Armand Dujardin, Olivier Bouché, et al.
Bulletin Du Cancer
|
February 15, 2020
[Localized MSI/dMMR gastric cancer patients, perioperative immunotherapy instead of chemotherapy: The GERCOR NEONIPIGA phase II study is opened to recruitment]
Romain Cohen, Thomas Pudlarz, Marie-Line Garcia-Larnicol, et al.
Seminars in Oncology
|
April 12, 2017
Prevention of 5-fluorouracil-induced early severe toxicity by pre-therapeutic dihydropyrimidine dehydrogenase deficiency screening: Assessment of a multiparametric approach
Michele Boisdron-Celle, Olivier Capitain, Roger Faroux, et al.
Clinical Colorectal Cancer
|
July 18, 2019
Efficacy and Safety of Two Neoadjuvant Strategies With Bevacizumab in MRI-Defined Locally Advanced T3 Resectable Rectal Cancer: Final Results of a Randomized, Noncomparative Phase 2 INOVA Study
Christophe Borg, Georges Mantion, Frank Boudghène, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
July 4, 2019
Infiltrating and peripheral immune cell analysis in advanced gastric cancer according to the Lauren classification and its prognostic significance
Simon Pernot, Magali Terme, Nina Radosevic-Robin, et al.
The Journal of Clinical Investigation
|
January 23, 2010
Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells
Fanny Chalmin, Sylvain Ladoire, Grégoire Mignot, et al.
Gastroenterology
|
November 29, 2024
ERBB2 Comprehensive Profiling and Prognostication in Stage III Colon Cancer: Findings From PETACC8 and IDEA-France Cohorts
Camilla Pilati, Audrey Soulabaille, Claire Gallois, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 9, 2008
EPIC: phase III trial of cetuximab plus irinotecan after fluoropyrimidine and oxaliplatin failure in patients with metastatic colorectal cancer
Alberto F Sobrero, Joan Maurel, Louis Fehrenbacher, et al.
Page
of 23